13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-13, with 27 holding rows worth $166,847,000.
- Accession
- 0001140361-18-007210
- Filer
- CIK 1440771
- Filed
- 2018-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 27 entries on the cover page, a total value of $166,847,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $166,847,000 with VALUE read as thousands by filing date, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VIVEVE MED INC | 92852W204 | COM NEW | 3,849,711 | $19,133,000 | thousands by filing date | |
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 385,954 | $16,723,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 2,560,314 | $14,338,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 885,000 | $13,452,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 218,434 | $12,818,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 3,645,491 | $10,754,000 | thousands by filing date | |
| SOCIETAL CDMO INC | 75629F109 | COM | 1,050,115 | $9,714,000 | thousands by filing date | |
| CUMBERLAND PHARMACEUTICALS I | 230770109 | COM | 1,306,911 | $9,619,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 1,235,147 | $8,066,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 2,350,000 | $7,332,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 920,000 | $6,753,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 1,694,717 | $5,288,000 | thousands by filing date | |
| CARDIOME PHARMA CORP | 14159U301 | COM NO PAR | 3,195,692 | $4,953,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 1,834,838 | $4,917,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 3,559,899 | $4,735,000 | thousands by filing date | |
| CANCER GENETICS INC. | 13739u104 | COM | 1,786,063 | $3,304,000 | thousands by filing date | |
| MEDICREA INTERNATIONAL | F6112U109 | COM | 713,693 | $2,568,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 344,282 | $2,496,000 | thousands by filing date | |
| STEADYMED LTD | M84920103 | SHS | 617,725 | $2,286,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 150,000 | $2,093,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 140,000 | $1,428,000 | thousands by filing date | |
| ACER THERAPEUTICS INC | 00444P108 | CMN | 100,000 | $1,385,000 | thousands by filing date | |
| VICAL INC | 925602203 | COM NEW | 676,232 | $1,238,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 225,000 | $691,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 40,500 | $476,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 67,647 | $217,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 17,533 | $70,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-18-007210 | this filing | 2018-02-13 | acceptance time not in the bulk data set |